Abstract
In this study, the investigators reviewed the efficacy and safety data from a pooled analysis of four randomized placebo-controlled trials of duloxetine for the treatment of late-life generalized anxiety disorder (GAD).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Davidson J, Allgulander C, Pollack MH, Hartford J, Erickson JS, Russell JM, Perahia D, Wohlreich MM, Carlson J, Raskin J. Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies. Hum Psychopharmacol. 2008;23(6):519–26.
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Joshi, P., Tampi, R.R. (2022). Efficacy and Tolerability of Duloxetine in Elderly Patients with Generalized Anxiety Disorder: A Pooled Analysis of Four Randomized, Double-Blind, Placebo-Controlled Studies. In: Tampi, R.R., Tampi, D.J., Young, J.J., Balasubramaniam, M., Joshi, P. (eds) Essential Reviews in Geriatric Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-030-94960-0_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-94960-0_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-94959-4
Online ISBN: 978-3-030-94960-0
eBook Packages: MedicineMedicine (R0)